May 1, 2019
The American Society of Clinical Oncology (ASCO) has released a new guideline that states that patients with clinically low-risk stage III colon cancer should have the option of receiving 3 months of adjuvant oxaliplatin-based chemotherapy. For patients at a high risk of recurrence (T4 and/or N2), adjuvant chemotherapy should be offered for a duration of […]
Tags: Colon Cancer, News Tips and Features, News Tips and Features Other
April 4, 2019
CD40 Combination Therapy Can Shrink Pancreatic Tumors
A new combination of immunotherapy and chemotherapy for pancreatic cancer caused tumors to shrink in the majority of evaluable patients – 20 out of 24 as of an interim analysis of the phase 1b trial data. The early findings provide hope that this strategy involving a CD40 antibody, a checkpoint inhibitor, and standard-of-care chemotherapy could […]
Tags: News Tips and Features, News Tips and Features Other, Pancreatic Cancer
March 18, 2019
Lynparza Delays Progression of BRCA-mutated Metastatic Pancreatic Cancer
Lynparza (olaparib) improves progression-free survival (PFS) when used to treat BRCA-mutated pancreatic cancer and appears to represent a new treatment option for this hard to treat cancer. (1-4) About BRCA Mutated Pancreatic Cancer Pancreatic cancer has the worst survival rate of the most common cancers and less than seven percent of patients survive more than […]
Tags: News Tips and Features, News Tips and Features Other, Pancreatic Cancer
March 8, 2019
The United States Food and Drug Administration (FDA) has approved Lonsurf® (trifluridine/tipiracil)) as a treatment for adult patients with metastatic gastric or gastroesophageal junction adenocarcinoma previously treated with at least two prior lines of chemotherapy that included a fluoropyrimidine, a platinum, either a taxane or irinotecan, and if appropriate, HER2/neu-targeted therapy. About Lonsurf Lonsurf consists of […]
Tags: Gastric Cancer, News Tips and Features, News Tips and Features Other
February 28, 2019
Results from the trial showed a significant and clinically-meaningful improvement in progression-free survival (PFS) with Lynparza (olaparib) for the treatment of BRCA-mutated pancreatic cancer. POLO is a randomised, double-blinded, placebo-controlled trial exploring the efficacy of Lynparza tablets as 1st-line maintenance monotherapy in patients with germline BRCA-mutated (gBRCAm) metastatic adenocarcinoma of the pancreas (pancreatic cancer) whose […]
Tags: News Tips and Features, News Tips and Features Other, Pancreatic Cancer
November 13, 2018
Keytruda Immunotherapy for Treatment of Liver Cancer
According to the results of a study presented at the recent gastrointestinal cancer symposia, Keytruda (pembrolizumab) is an active treatment for advanced liver cancer in patients who have already been treated with Nexavar (sorafenib), (1) and has not been approved by the US for use in patients with liver cancer. Keytruda was approved as a […]
Tags: Liver Cancer, News Tips and Features, News Tips and Features Other
October 19, 2018
Laurie MacCaskill Partners with CancerConnect
KETCHUM – LOS ANGELES: Laurie MacCaskill, a 12-year survivor of pancreatic cancer and former chair of the Pancreatic Cancer Action Network has announced a newly established partnership with Cancer Connect to support pancreatic cancer patients with information, support and inspiration. Cancer Connect, a national organization provides support and information to more than 1 million patients […]
Tags: News Tips and Features, News Tips and Features Other, Pancreatic Cancer
August 20, 2018
FDA Approves Lenvatinib for Treatment of Advanced Hepatocellular Cancer
The U.S. Food and Drug Administration (FDA) approved the kinase inhibitor LENVIMA® (lenvatinib) for the first-line treatment of patients with unresectable hepatocellular carcinoma (HCC). This approval was based on results from REFLECT, where LENVIMA demonstrated a proven treatment effect on overall survival as well as statistically significant superiority and clinically meaningful improvements in progression-free survival […]
Tags: Liver Cancer, News Tips and Features, News Tips and Features Other
 |
 |
 |
